Old-line diabetes drug may fight diseases of aging
The News Journal
Just over a year ago, Catherine Price decided to start taking one of the cheapest, safest, oldest, most widely prescribed drugs for Type 2 diabetes. So much is taken in the United States – some 72 million prescriptions were written for it in 2013

diabetes – Google News


CBS News
Drug shows promise for treating type 1 diabetes
CBS News
A drug that's been on the market for years is showing new promise for treating type 1 diabetes, the form of the disease that often strikes during childhood. Researchers at Massachusetts General Hospital are launching a 5-year clinical trial of a
100-Year-Old Vaccine May Help Reverse Type 1 DiabetesCBS Local
Diabetes Vaccine PromisingWTAJ
Diabetes VaccineSiouxland News
WKRC TV Cincinnati -WCAX
all 9 news articles »

diabetes – Google News


Healthline
Combination of Stem Cell and Drug Therapy Could Reverse Type 2 Diabetes
Healthline
While people with type 2 diabetes do lose some of theirinsulin-producing cells, their primary problem is elsewhere. Their cells havebecome resistant to insulin. Although insulin is present in the body, the cellscan no longer use insulin to keep blood

diabetes – Google News


International Business Times
Japan's Takeda Agrees to Pay $ 2.4 Bln in Diabetes Drug Suit
ABC News
Japan's largest drugmaker Takeda Pharmaceutical Co. said Wednesday it has agreed to pay up to $ 2.4 billion to thousands of patients and their families over its diabetes drug Actos which has been linked to cancer. Takeda has faced product liability
Japan's Takeda Agrees To $ 2.4B Settlement In Diabetes Drug Actos Lawsuit International Business Times
Takeda warns of loss after $ 2.4 bn diabetes drug settlementsYahoo News

all 126 news articles »

diabetes – Google News


Bloomberg
Merck's diabetes drug Januvia succeeds in heart safety trial
Reuters
(Reuters) – Merck and Co's diabetes drug Januvia achieved the main goal of a long-awaited heart safety study, according to preliminary results released by the drugmaker on Monday, likely removing a cloud of uncertainty from its biggest product.
Merck Gains as Januvia Diabetes Drug Doesn't Add to Heart RiskBloomberg

all 94 news articles »

diabetes – Google News


Science Daily
Diabetes drug found in freshwater is a potential cause of intersex fish
Science Daily
A study by Rebecca Klaper at the University of Wisconsin-Milwaukee determined exposure to the diabetes medicine metformin causes physical changes in male fish exposed to doses similar to the amount in wastewater effluent. In addition to intersex …
Diabetes drug metformin linked with intersex freshwater fishUPI.com
Diabetes drug metformin found in freshwater is potential cause of intersex fishScience Codex
Male fish producing eggs due to diabetes drug traces in freshwaterInternational Business Times UK
Zee News
all 12 news articles »

diabetes – Google News


MedPage Today
Investigational Diabetes Drug Eyed for Steatohepatitis
MedPage Today
Note that this randomized trial of a novel type-2 diabetes agent showed promise in reducing alanine aminotransferase levels, suggesting it may have a role in NASH. Be aware that the beneficial effect on liver enzymes may have been due to weight loss.

diabetes – Google News


Bloomberg
AstraZeneca's diabetes drug Onglyza may increase death rate -FDA
AOL News
In December 2008, the FDA issued guidance requiring drug companies to conduct studies to show that new diabetes drugs do not increase cardiovascular risk. The guidance was developed amid growing concern about the safety of many diabetes drugs.
AstraZeneca's Diabetes Drug May Raise Death Risk, FDA SaysBloomberg
AstraZeneca diabetes drug may increase risk of heart failure and deathModernHealthcare.com

all 48 news articles »

diabetes – Google News


Bloomberg
FDA pulls diabetes drug citing increased risk of death – AOL.com
AOL News
The Food and Drug Administration is pulling a Type 2 diabetes drug produced by AstraZeneca off the market after a new study shows it increases overall death rates in patients. According to their study, patients who took Onglyza were at a greater risk
AstraZeneca's diabetes drug Onglyza may increase death rate -FDAReuters
AstraZeneca's Diabetes Drug May Raise Death Risk, FDA SaysBloomberg
AstraZeneca diabetes drug may increase risk of heart failure and deathModernHealthcare.com

all 48 news articles »

diabetes – Google News

Should FDA Penalize Drug Makers Over Diabetes Drug Ads?
Wall Street Journal (blog)
A consumer watchdog has asked the FDA to stop several drug makers from promoting their diabetes medicines for losing weight, because the drugs were not approved for this purpose. In a letter to the FDA, Public Citizen says the ads are ubiquitous – they …
Off-label promotions of diabetes meds sometimes nonsensical, watchdog warns McKnight’s Long Term Care News
FDA Must Block Off-Label Diabetes Drug Promos, Group SaysLaw360 (subscription)

all 5 news articles »

diabetes – Google News